An Analysis of samples from breast cancer patients showed that NDRG4 was highly methylated, and patients with methylated NDRG4 had worse overall and distant metastasis-free survival relative to those with non-methylated NDRG4 tumors. Here, NDRG4 is linked to breast carcinoma.